I am an NHMRC-ARC Dementia Research Development Fellow and Lecturer of Pharmacy Practice (at UniSA since 2019). I am also a qualified pharmacist with experience working as a clinical pharmacist in a large tertiary teaching hospital. I completed my PhD at the University of South Australia in 2014 and was awarded the medal from the School of Pharmacy and Medical Sciences for my thesis work. Following this I was a postdoctoral research associate at the University of Sydney with the NHMRC Cognitive Decline Partnership Centre. I also spent two months as a visiting researcher at the Brocher Foundation (Geneva, Switzerland) in 2014. The first two years of my fellowship were undertaken in Canada with the University of Sydney and the Department of... Read more
About me
I am an NHMRC-ARC Dementia Research Development Fellow and Lecturer of Pharmacy Practice (at UniSA since 2019). I am also a qualified pharmacist with experience working as a clinical pharmacist in a large tertiary teaching hospital. I completed my PhD at the University of South Australia in 2014 and was awarded the medal from the School of Pharmacy and Medical Sciences for my thesis work. Following this I was a postdoctoral research associate at the University of Sydney with the NHMRC Cognitive Decline Partnership Centre. I also spent two months as a visiting researcher at the Brocher Foundation (Geneva, Switzerland) in 2014. The first two years of my fellowship were undertaken in Canada with the University of Sydney and the Department of Medicine at Dalhousie University, and I hold affiliate status with the College of Pharmacy, Dalhousie University. My fellowship work is also being conducted in collaboration with the Deprescribing in the Elderly Project group at the Bruyère Research Institute (Ottawa, Canada).
About me
Doctor of Philosophy University of South Australia
Bachelor of Pharmacy University of South Australia
Research
Excludes commercial-in-confidence projects.
Integration and implementation of deprescribing recommendations to reducemedication induced harm, NHMRC - Investigator Grants, 01/01/2021 - 31/12/2025
Optimal Medication Management in Alzheimer's Disease and Dementia, National Institute of Health, 04/01/2019 - 31/01/2022
Consumer and clinician led priority setting for the NNIDR MEDicines and DEMentia (MEDDEM) National Research Action Plan, Australian Association of Gerontology Inc., 01/01/2020 - 21/12/2021
Development and implementation of evidence-based deprescribing guidelines to guide person-centred care for people with dementia, NHMRC - ARC Dementia Research Development Fellowship, 01/02/2016 - 28/02/2021
Use of antipsychotic medicines for people aged 65 years and over: A review undertaken for the Australian Commission on Safety and Quality in Health Care, Northern Sydney Area Health Service, 15/04/2019 - 29/11/2019
Research
Research since 2008 is shown below. To see earlier years visit ORCID or Scopus
Open access indicates that an output is open access.
Year | Output |
---|---|
2020 |
|
2019 |
|
Year | Output |
---|---|
2020 |
Open access
|
2020 |
Open access
2
17
|
2020 |
Open access
1
|
2020 |
1
7
|
2020 |
Open access
18
|
2020 |
9
|
2020 |
Open access
1
|
2020 |
43
|
2020 |
Open access
12
|
2020 |
|
2020 |
Open access
3
2
8
|
2020 |
9
|
2020 |
|
2020 |
1
|
2020 |
Open access
3
104
|
2020 |
2
6
|
2020 |
3
3
14
|
2019 |
2
1
|
2019 |
Open access
4
3
38
|
2019 |
Open access
2
1
8
|
2019 |
Open access
4
2
8
|
2019 |
Open access
3
3
5
|
2019 |
2
2
3
|
2019 |
Open access
1
1
4
|
2019 |
Open access
4
3
1
|
2019 |
Open access
12
10
61
|
2019 |
Open access
16
14
105
|
2019 |
Open access
14
10
27
|
2018 |
Open access
7
8
8
|
2018 |
Open access
6
5
8
|
2018 |
Open access
13
8
9
|
2018 |
Open access
22
25
18
|
2018 |
Open access
49
47
278
|
2017 |
Open access
3
9
|
2017 |
Open access
9
6
|
2017 |
Open access
8
5
5
|
2017 |
1
|
2017 |
Open access
4
4
27
|
2017 |
Open access
46
36
42
|
2017 |
Open access
84
78
24
|
2017 |
Open access
25
22
30
|
2017 |
Open access
35
34
2
|
2017 |
Open access
4
2
|
2016 |
40
35
31
|
2016 |
|
2016 |
33
32
21
|
2016 |
42
41
17
|
2016 |
17
13
3
|
2016 |
Open access
58
54
4
|
2016 |
49
43
26
|
2016 |
16
13
4
|
2015 |
12
13
1
|
2015 |
10
11
3
|
2015 |
56
54
8
|
2015 |
6
3
|
2015 |
52
37
8
|
2015 |
52
46
|
2015 |
Open access
2
2
|
2015 |
Open access
187
160
55
|
2015 |
48
49
3
|
2015 |
Open access
557
492
577
|
2015 |
17
16
|
2014 |
50
44
8
|
2014 |
Open access
138
127
47
|
2014 |
Open access
57
39
7
|
2014 |
Open access
30
30
2
|
2013 |
50
44
|
2013 |
Open access
217
195
43
|
2013 |
121
106
15
|
Year | Output |
---|---|
2020 |
Open access
|
2018 |
Open access
|
2018 |
Open access
|
External engagement & recognition
External engagement & recognition
Engagement/recognition | Year |
---|---|
Dementia Research Development FellowshipNational Health and Medical Research Council (NHMRC) Australian Research Council (ARC) |
2020 |
Executive Committee Member and Chair of Public Engagement SubcommitteeAustralian Deprescribing Network (ADeN) |
2020 |
Invited SpeakerAustralian Association of Consultant Pharmacy (AACP) 16th Annual Consultant Clinical Pharmacy Seminar |
2020 |
Invited to provide input on: Baseline report on Quality Use of Medicines and Medicines Safety ‰ÛÒ Discussion paper for public consultationAustralian Commission on Safety and Quality in Health Care |
2020 |
MemberSociety of Hospital Pharmacists of Australia (SHPA) |
2020 |
MemberAustralasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) |
2020 |
MemberAustralasian Pharmaceutical Science Association (APSA) |
2020 |
MemberAustralian Association of Gerontology (AAG) |
2020 |
Member of the Investigator Development Core and Expert ConsultantUnited States Deprescribing Research Network (USDeN) |
2020 |
Steering Committee MemberGuidelines International Network (G.I.N.) Australia and New Zealand (ANZ) |
2020 |
Best 'Rapid Fire' Oral PresentationTheo Murphy Australian Frontiers of Science Redefining Health Ageing Together (Australian Academy of Science) Conference |
2019 |
Dementia Research Development FellowshipNational Health and Medical Research Council (NHMRC) Australian Research Council (ARC) |
2019 |
Executive Committee Member and Chair of Public Engagement SubcommitteeAustralian Deprescribing Network (ADeN) |
2019 |
Founding MemberAustralian Deprescribing Network (ADeN) |
2019 |
Invited Speaker, Annual Scientific MeetingAmerican Geriatrics Society (AGS) |
2019 |
MemberAustralian Association of Gerontology (AAG) |
2019 |
MemberSociety of Hospital Pharmacists of Australia |
2019 |
MemberAustralasian Society of Clinical and Experimental Pharmacologists and Toxicologists |
2019 |
MemberGerontological Society of America |
2019 |
MemberRoyal North Shore Hospital Scientific Staff Council |
2019 |
MemberNHMRC National Institute for Dementia Research |
2019 |
MemberAustralasian Pharmaceutical Science Association |
2019 |
MemberSydney Dementia Network (dementia) |
2019 |
Member of the Investigator Development Core and Expert ConsultantUnited States Deprescribing Research Network (USDeN) |
2019 |
Plenary speakerHouston Medication Safety Symposium |
2019 |
Plenary Speaker, Annual MeetingAustralian Deprescribing Network (ADeN) |
2019 |
Early Achievement Award for Women: 2018Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) |
2018 |
Expert Consultant on National Report on Polypharmacy: Medication Overload: How the drive to prescribe is harming older AmericansLown Institute |
2018 |
Founding MemberAustralian Deprescribing Network (ADeN) |
2018 |
Invited SpeakerCanadian Frailty Network Conference, Canada |
2018 |
Invited SpeakerSwiss Society of Internal Medicine Annual Meeting, Switzerland |
2018 |
MemberSociety of Hospital Pharmacists of Australia |
2018 |
MemberAustralasian Society of Clinical and Experimental Pharmacologists and Toxicologists |
2018 |
MemberGerontological Society of America |
2018 |
MemberRoyal North Shore Hospital Scientific Staff Council |
2018 |
MemberNHMRC National Institute for Dementia Research |
2018 |
MemberAustralasian Pharmaceutical Science Association |
2018 |
MemberSydney Dementia Network (dementia) |
2018 |
Organising Committee Member, Invited Presenter, Panel Member and Workshop FacilitatorEvidence-Based Deprescribing Guideline Symposium, Canada |
2018 |
Dementia Research Development FellowshipNational Health and Medical Research Council (NHMRC) Australian Research Council (ARC) |
2017 |
Founding MemberAustralian Deprescribing Network (ADeN) |
2017 |
Invited SpeakerNorthwood Research Symposium, Canada |
2017 |
Invited Speaker and Panel MemberPharmacy Association of Nova Scotia Annual Conference, Canada |
2017 |
MemberSociety of Hospital Pharmacists of Australia |
2017 |
MemberAustralasian Society of Clinical and Experimental Pharmacologists and Toxicologists |
2017 |
MemberGerontological Society of America |
2017 |
MemberRoyal North Shore Hospital Scientific Staff Council |
2017 |
MemberNHMRC National Institute for Dementia Research |
2017 |
MemberAustralasian Pharmaceutical Science Association |
2017 |
Symposium Chair and Presenter21st IAGG World Congress of Gerontology and Geriatrics |
2017 |
Best Oral Presentation (rapid fire presentations)Australian National Dementia Forum, Brisbane |
2016 |
Dementia Research Development FellowshipNational Health and Medical Research Council (NHMRC) Australian Research Council (ARC) |
2016 |
Emerging Health Researcher Award Finalist: 2016Bupa Health Foundation |
2016 |
Founding MemberAustralian Deprescribing Network (ADeN) |
2016 |
Invited SpeakerAustralasian Pharmaceutical Science Association Annual Conference, Sydney |
2016 |
MemberSociety of Hospital Pharmacists of Australia |
2016 |
MemberAustralasian Society of Clinical and Experimental Pharmacologists and Toxicologists |
2016 |
MemberGerontological Society of America |
2016 |
MemberRoyal North Shore Hospital Scientific Staff Council |
2016 |
MemberNHMRC National Institute for Dementia Research |
2016 |
MemberAustralasian Pharmaceutical Science Association |
2016 |
Founding MemberAustralian Deprescribing Network (ADeN) |
2015 |
Invited Session ChairAustralian Pharmaceutical Sciences Association (APSA), Australian Society of Clinical and Experimental Pharmacology and Toxicology (ASCEPT) Joint Meeting |
2015 |
Invited SpeakerMedicines Management, 41st SHPA National Conference, Melbourne |
2015 |
MemberSociety of Hospital Pharmacists of Australia |
2015 |
MemberAustralasian Society of Clinical and Experimental Pharmacologists and Toxicologists |
2015 |
MemberGerontological Society of America |
2015 |
MemberRoyal North Shore Hospital Scientific Staff Council |
2015 |
Workshop ConvenorAustralian Deprescribing Network Annual Workshop, Sydney |
2015 |
Early Career Research Award Presentation (Finalist)New Horizons (Kolling Institute, NSW) |
2014 |
Founding MemberAustralian Deprescribing Network (ADeN) |
2014 |
Invited SpeakerDeprescribing Workshop, Australian Deprescribing Network, Brisbane |
2014 |
MemberSociety of Hospital Pharmacists of Australia |
2014 |
MemberAustralasian Society of Clinical and Experimental Pharmacologists and Toxicologists |
2014 |
MemberGerontological Society of America |
2014 |
MemberRoyal North Shore Hospital Scientific Staff Council |
2014 |
MemberSociety of Hospital Pharmacists of Australia |
2013 |
Invited SpeakerAustralian Association of Consultant Pharmacists meeting, Pharmacy Congress Australia |
2012 |
MemberSociety of Hospital Pharmacists of Australia |
2012 |
MemberSociety of Hospital Pharmacists of Australia |
2011 |
MemberSociety of Hospital Pharmacists of Australia |
2010 |
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
Assessment of adherence and assessing drug concentration effect relationships in patients with rheumatoid arthritis and scleroderma. | Current |
Comparison of different methods to assess adherence to weekly methotrexate and hydroxychloroquine | Current |
Developing strategies to promote the use of treat to target strategies with conventional synthetic disease modifying anti-rheumatic drugs in patients with early rheumatoid arthritis | Current |